Working... Menu

Pasireotide, Everolimus and Selective Internal Radioembolization Therapy for Unresectable Hepatic Metastases

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01469572
Recruitment Status : Completed
First Posted : November 10, 2011
Last Update Posted : October 18, 2018
Information provided by (Responsible Party):
Bassel El-Rayes, Emory University

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : October 2018
  Actual Study Completion Date : October 2018